Michael Ricciardi, Ph.D.
About Michael Ricciardi, Ph.D.
Michael Ricciardi, Ph.D., serves as the Associate Director of Translational Research at The George Washington University, where he focuses on developing diagnostic tests and isolating neutralizing antibodies for viral infections. He has a strong background in biochemistry and molecular biology, with previous roles at the University of Miami and experience in vaccine trials and immune response studies.
Work at The George Washington University
Michael Ricciardi, Ph.D. serves as the Associate Director of Translational Research at The George Washington University since 2020. In this role, he focuses on advancing research initiatives that translate scientific discoveries into practical applications. His current projects include isolating broadly neutralizing monoclonal antibodies against SARS-CoV-2 and evaluating their effectiveness against various Coronaviruses. Ricciardi's work contributes to the understanding and management of viral infections, particularly in the context of public health.
Education and Expertise
Michael Ricciardi obtained his Doctorate of Philosophy in Biochemistry and Molecular Biology from the University of Miami, where he studied monoclonal antibodies for use in vaccines, diagnostics, and therapeutics. He also holds a Master's degree in Public Health and a Bachelor's degree in Microbiology and Immunology from the same institution. His educational background equips him with a strong foundation in both the scientific and public health aspects of infectious diseases.
Background in Research and Development
Before his current position, Michael Ricciardi worked at the University of Miami, Miller School of Medicine for eight years, where he held roles as Lab Manager and Research Associate. His experience includes leading the development of a Zika virus-specific diagnostic test, which involved evaluating a highly-specific monoclonal antibody. He also co-founded Z-Quick Diagnostics, where he managed operations and contributed to the development of diagnostic solutions.
Achievements in Viral Research
Michael Ricciardi has made significant contributions to viral research, including conducting a vaccine trial using Adeno-associated virus and Sendai virus vectors to elicit immune responses against HIV/SIV in non-human primates. He authored an IRB-approved study to monitor immune responses in individuals infected with Zika virus and SARS-CoV-2. His research has also revealed insights into how Dengue virus and other Flaviviruses can evade immune responses by altering their viral surface structure.